<DOC>
	<DOC>NCT00959335</DOC>
	<brief_summary>The purpose of this study is to demonstrate the relative bioavailability of Bicalutamide 50 mg tablet and Casodex following a 50 mg dose in healthy subjects under fasting conditions.</brief_summary>
	<brief_title>Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Hirsutism</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Positive test results for HIV or hepatitis B or C. Treatment for drug or alcohol dependence.</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>63 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>treatment</keyword>
</DOC>